{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:38:17Z","timestamp":1792165097585,"version":"4.4.0"},"reference-count":32,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"GLWL Research, Inc"},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Acylated ghrelin (AG) stimulates appetite and is elevated compared to its unacylated (UAG) counterpart in Prader-Willi syndrome (PWS). GLWL-01 is a selective, reversible inhibitor of ghrelin O-acyltransferase (GOAT), the enzyme that converts UAG into AG.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This work aimed to assess the efficacy, pharmacokinetics, pharmacodynamics, and safety of GLWL-01 in the treatment of PWS patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A double-blind, placebo-controlled, phase 2 crossover study was conducted with 2 active treatment periods of 28 days in 19 patients (aged 16-65 years; body mass index (BMI)\u2005\u2265\u200528) with genetically confirmed PWS. The study took place in 7 hospital-based study centers in the United States and Canada. Patients received placebo or GLWL-01 (450 mg twice daily) orally after lead-in placebo and washout periods. The Hyperphagia Questionnaire for Clinical Trials and Caregiver Global Impression of Change were used to measure reductions in hyperphagia. Plasma concentrations of AG and UAG were evaluated as correlates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Treatment resulted in statistically significant differences compared to placebo in plasma AG (P\u2005=\u2005.0002), UAG (P\u2005=\u2005.0488), and AG\/UAG (P\u2005=\u2005.0003). GLWL-01 did not statistically significantly reduce hyperphagia-related behavior or bring about changes in global clinical end points, as assessed by caregivers. Anthropometric and clinical parameters correlated with obesity did not statistically significantly change in response to treatment. Less than half of patients reported a treatment-emergent adverse event (TEAE). No deaths, serious adverse events, or severe TEAEs were reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>GLWL-01 is safe and well tolerated. Pharmacological parameters confirmed the inhibition of GOAT following administration of GLWL-01. Patients\u2019 eating behaviors, BMI, blood glucose, and total cholesterol, among other similar measures, were not modified.<\/jats:p><\/jats:sec>","DOI":"10.1210\/clinem\/dgac105","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T18:43:14Z","timestamp":1645814594000},"page":"e2373-e2380","source":"Crossref","is-referenced-by-count":20,"title":["The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi Syndrome"],"prefix":"10.1210","volume":"107","author":[{"given":"Jennifer L","family":"Miller","sequence":"first","affiliation":[{"name":"University of Florida , Gainesville, Florida 32611 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0225-2749","authenticated-orcid":false,"given":"Andr\u00e9","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de l\u2019Universit\u00e9 \u00a0 de Montr\u00e9al (CHUM), Montr\u00e9al, Qu\u00e9bec H2X 3J4 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M","family":"Bird","sequence":"additional","affiliation":[{"name":"University of California San Diego and Rady Children\u2019s Hospital , San Diego, California 92123 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1628-3677","authenticated-orcid":false,"given":"Ashley H","family":"Shoemaker","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center , Nashville, Tennessee 37232 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Haqq","sequence":"additional","affiliation":[{"name":"Alberta Diabetes Institute, University of Alberta , Edmonton, Alberta T6G 2T9 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheri L","family":"Deal","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire Ste-Justine , Montr\u00e9al, Qu\u00e9bec H3T 1C5 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie A","family":"Clark","sequence":"additional","affiliation":[{"name":"Lilly Chorus , Indianapolis, Indiana 46285 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Ames","sequence":"additional","affiliation":[{"name":"EMB Statistical Solutions LLC , Overland Park, Kansas 66210 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G","family":"Suico","sequence":"additional","affiliation":[{"name":"Lilly Chorus , Indianapolis, Indiana 46285 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"de la Pe\u00f1a","sequence":"additional","affiliation":[{"name":"Lilly Chorus , Indianapolis, Indiana 46285 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5350-1245","authenticated-orcid":false,"given":"Caroline","family":"Fortier","sequence":"additional","affiliation":[{"name":"GLWL Research Inc , Montreal, Qu\u00e9bec H3B 3X3 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"issue":"3","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/138920211795677877","article-title":"Prader-Willi syndrome: obesity due to genomic imprinting","volume":"12","author":"Butler","year":"2011","journal-title":"Curr Genomics."},{"issue":"1","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tem.2003.11.003","article-title":"Prader-Willi syndrome: advances in genetics, pathophysiology and treatment","volume":"15","author":"Goldstone","year":"2004","journal-title":"Trends Endocrinol Metab."},{"key":"2023033006512055600_","author":"Strong"},{"key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2015.12.003","article-title":"Single gene and syndromic causes of obesity: illustrative examples","volume":"140","author":"Butler","year":"2016","journal-title":"Prog Mol Biol Transl Sci."},{"issue":"1","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet Med."},{"key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2147\/TCRM.S70068","article-title":"Growth hormone therapy for Prader-Willi syndrome: challenges and solutions","volume":"12","author":"Grugni","year":"2016","journal-title":"Ther Clin Risk Manag."},{"issue":"6","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gim.2016.178","article-title":"Causes of death in Prader-Willi syndrome: Prader-Willi Syndrome Association (USA) 40-year mortality survey","volume":"19","author":"Butler","year":"2017","journal-title":"Genet Med."},{"issue":"5277","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.273.5277.974","article-title":"A receptor in pituitary and hypothalamus that functions in growth hormone release","volume":"273","author":"Howard","year":"1996","journal-title":"Science."},{"issue":"5","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2012-4247","article-title":"Clinical review: the human experience with ghrelin administration","volume":"98","author":"Garin","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12020-015-0614-x","article-title":"Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome","volume":"50","author":"Kuppens","year":"2015","journal-title":"Endocrine."},{"issue":"6762","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature."},{"issue":"6817","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35051587","article-title":"A role for ghrelin in the central regulation of feeding","volume":"409","author":"Nakazato","year":"2001","journal-title":"Nature."},{"issue":"4","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/pr.109.001958","article-title":"Ghrelin gene products and the regulation of food intake and gut motility","volume":"61","author":"Chen","year":"2009","journal-title":"Pharmacol Rev."},{"issue":"4","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1124\/pr.113.008433","article-title":"Novel and conventional receptors for ghrelin, desacyl-ghrelin, and pharmacologically related compounds","volume":"66","author":"Callaghan","year":"2014","journal-title":"Pharmacol Rev."},{"issue":"12","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","article-title":"Ghrelin enhances appetite and increases food intake in humans","volume":"86","author":"Wren","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.physbeh.2010.10.017","article-title":"Signaling through the ghrelin receptor modulates hippocampal function and meal anticipation in mice","volume":"103","author":"Davis","year":"2011","journal-title":"Physiol Behav."},{"issue":"6","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"M\u00fcller","year":"2015","journal-title":"Mol Metab."},{"issue":"1","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mce.2011.02.017","article-title":"The role of the central ghrelin system in reward from food and chemical drugs","volume":"340","author":"Dickson","year":"2011","journal-title":"Mol Cell Endocrinol."},{"key":"2023033006512055600_","first-page":"107","article-title":"Clinical management of behavioral characteristics of Prader-Willi syndrome","volume":"6","author":"Ho","year":"2010","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"5","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"e12992","DOI":"10.1111\/obr.12992","article-title":"Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: a narrative review","volume":"21","author":"Tan","year":"2020","journal-title":"Obes Rev."},{"key":"2023033006512055600_","first-page":"113","article-title":"Dietary management for adolescents with Prader-Willi syndrome","volume":"11","author":"Miller","year":"2020","journal-title":"Adolesc Health Med Ther."},{"issue":"21","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med."},{"issue":"6","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/pst.1638","article-title":"A recommended analysis for 2\u2005\u00d7\u20052 crossover trials with baseline measurements","volume":"13","author":"Mehrotra","year":"2014","journal-title":"Pharm Stat."},{"issue":"6","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1530\/EJE-13-0072","article-title":"The pharmacokinetics of acyl, des-acyl, and total ghrelin in healthy human subjects","volume":"168","author":"Tong","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1530\/EJE-13-0347","article-title":"Does des-acyl ghrelin improve glycemic control in obese diabetic subjects by decreasing acylated ghrelin levels?","volume":"170","author":"\u00d6zcan","year":"2014","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/EJE-14-1131","article-title":"Does des-acyl ghrelin improve glycemic control by decreasing acylated ghrelin levels?","volume":"173","author":"Gaylinn","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1210\/jc.2003-031964","article-title":"Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans","volume":"89","author":"Broglio","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1096\/fj.12-221143","article-title":"Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis","volume":"27","author":"Delhanty","year":"2013","journal-title":"FASEB J."},{"key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.peptides.2017.12.015","article-title":"Ghrelin regulation of glucose metabolism","volume":"100","author":"Poher","year":"2018","journal-title":"Peptides."},{"issue":"1","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.gastro.2005.04.015","article-title":"Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats","volume":"129","author":"Chen","year":"2005","journal-title":"Gastroenterology."},{"issue":"1","key":"2023033006512055600_","doi-asserted-by":"crossref","first-page":"e0190849","DOI":"10.1371\/journal.pone.0190849","article-title":"AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: a randomized placebo-controlled trial","volume":"13","author":"Allas","year":"2018","journal-title":"PLoS One."},{"issue":"2","key":"2023033006512055600_","first-page":"90","article-title":"Ghrelin\u2014physiological functions and regulation","volume":"11","author":"Ibrahim Abdalla","year":"2015","journal-title":"Eur Endocrinol."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac105\/43369471\/dgac105.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/6\/e2373\/49693796\/dgac105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/6\/e2373\/49693796\/dgac105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T03:32:11Z","timestamp":1700278331000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/6\/e2373\/6537117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,2,25]]},"published-print":{"date-parts":[[2022,5,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac105","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,2,25]]}}}